KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $48.1 million.

  • Chemed's Accounts Payables rose 702.52% to $48.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.1 million, marking a year-over-year increase of 702.52%. This contributed to the annual value of $44.1 million for FY2024, which is 3105.85% down from last year.
  • As of Q3 2025, Chemed's Accounts Payables stood at $48.1 million, which was up 702.52% from $50.9 million recorded in Q2 2025.
  • Chemed's Accounts Payables' 5-year high stood at $77.2 million during Q3 2022, with a 5-year trough of $40.3 million in Q1 2023.
  • In the last 5 years, Chemed's Accounts Payables had a median value of $55.4 million in 2021 and averaged $54.7 million.
  • As far as peak fluctuations go, Chemed's Accounts Payables soared by 5290.31% in 2021, and later crashed by 4449.75% in 2023.
  • Over the past 5 years, Chemed's Accounts Payables (Quarter) stood at $73.0 million in 2021, then crashed by 42.64% to $41.9 million in 2022, then surged by 52.88% to $64.0 million in 2023, then plummeted by 31.06% to $44.1 million in 2024, then increased by 8.95% to $48.1 million in 2025.
  • Its Accounts Payables stands at $48.1 million for Q3 2025, versus $50.9 million for Q2 2025 and $47.7 million for Q1 2025.